Health Canada
NOTICE
Health Canada updates guidance on management of drug submissions and applications: Notice
Published: 10/1/2025Detected: 3/22/2026
Summary preview
Updates to the management of drug submissions and applications introduce new timelines for the submission process and enhanced requirements for reporting quality issues.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
safety
#drug submissions
#quality reporting
#regulatory process
#electronic submissions
#safety monitoring
Official Source Document Source Verified
Access the original document directly from HEALTH CANADA.
More from Health Canada
- Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination10/2/2026
- Advisory Committee: National Pharmacare Committee of Experts10/2/2026
- Advisory Committee: Ministerial Advisory Council on Mental Health10/2/2026
- Advisory Committee: Expert Task Force on Substance Use10/2/2026
- Advisory Committee: Expert Panel on MAID and Mental Illness10/2/2026